A Phase I Study of PP-001 Eye Drops in Healthy Adult Volunteers
Status:
Active, not recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
In this study, PP-001 eye drops are assessed for safety and tolerability in healthy, adult
volunteers. PP-001 is a novel, anti-inflammatory small molecule that inhibits a specific
enzyme (Dihydroorotate Dehydrogenase).